Higuchi Tsukasa, Yoshizawa Kazuki, Hatata Tomoko, Yoshizawa Katsumi, Takamizawa Shigeru, Kobayashi Jun, Kubota Noriko, Hidaka Eiko
Department of General Pediatrics, Nagano Children's Hospital, Azumino, Japan.
Life Science Research Center, Nagano Children's Hospital, Azumino, Japan.
J Pediatr Genet. 2020 Oct 5;11(3):240-244. doi: 10.1055/s-0040-1718385. eCollection 2022 Sep.
gene variances confer susceptibility to Hirschsprung's disease (HSCR) with pathogenetic mutations being identified in half of familial cases. This investigation of familial HSCR was aimed to clarify the relationship between genetic mutations and clinical phenotype using next-generation sequencing. A novel c2313C > G(D771E) mutation was identified in all three affected family members. The mutation involved the kinase domain, which is believe to impair activity and intestinal function. A second mutation, c1465G > A(D489N), was found only in the extensive aganglionosis case. We conclude that the novel c2313C > A(D771E) mutation in may be pathogenic for HSCR, while the c1465C > G(D489N) mutation may be related to phenotype severity.
基因变异使个体易患先天性巨结肠症(HSCR),在半数家族性病例中已鉴定出致病突变。这项对家族性HSCR的研究旨在通过新一代测序来阐明基因突变与临床表型之间的关系。在所有三名受影响的家庭成员中均鉴定出一种新的c2313C>G(D771E)突变。该突变涉及激酶结构域,据信会损害其活性和肠道功能。仅在广泛性神经节缺失病例中发现了第二种突变,即c1465G>A(D489N)。我们得出结论,新发现的c2313C>A(D771E)突变可能是HSCR的致病原因,而c1465C>G(D489N)突变可能与表型严重程度有关。